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Introduction  
 
The pharmaceutical industry operates globally, generates a massive amount of income and affects 
almost everyone in the developed world (Davis, 2010). Specifically, medication is produced and 
prescribed in large volumes every year, for example over 100 tonnes of the top three compounds 
medications are prescribed in the UK each year (Xie and Breen, 2012).  Furthermore, pharmaceutical 
prescription represents the highest non-staff revenue cost in the UK National Health Service (NHS) 
(Savage et al, 2006).  This high cost is the reason why there has been pressure on the NHS, and 
generally on healthcare organisations, to keep a tight rein on their drugs spending.  The annual drugs 
bill in the UK is approximately £10 billion, which equates to about 10% of NHS expenditure, having 
risen 3.5% a year between 2007 and 2011 (McKee, 2012).  Despite the fact that the drug industry has 
agreed to £12bn NHS bill cap, to keep the bill for more expensive branded medicines flat for two 
years (Boseley, 2013), in this era of austerity there is an immense focus and accountability for funds 
spent within the NHS.  
 
Hospital pharmacies are looking for cost saving, waste elimination and better services through 
improving their Supply Chain Management (SCM) (AT Kearney, 2009). It is believed that they can 
minimise waste and maximise patient satisfaction and wellbeing by managing not only the forward 
components but also the reverse components of the logistics process (Jamali et al., 2010). The 
application of improvement tools and methods such as Lean thinking is considered necessary in 
order that the dominant causes of waste and the management practices that trigger waste in PSC are 
identified (Holden, 2011). 
 
This paper presents a preliminary examination of the deployment of lean and reverse logistics within 
the PSC. The authors believe that the Lean Philosophy can be applied to recognise process variations 
and identify explicit causes of waste. 
 
Literature review 
 
The complexity of modern markets, and demand for products and services in combination with the 
continuing development of technology make supply chains a popular choice for investigation by a 
number of researchers (Dobbs et al., 2011). Major supply chain disruptions can significantly reduce 
the stock market value of a company (Mustaffa and Potter, 2009).  The challenge, therefore, for 
those involved in managing supply chains is not only to manage the forward components of the 
logistics process in order to minimise waste and maximise consumer satisfaction and wellbeing but, 
increasingly, to manage and improve the reverse components as well (Pokharel and Mutha, 2009).  In 
other words, the need for the re-use or recycling of unwanted stock has become a major issue in 
many industries (Rupnow, 2007) such as: electronic waste (Lau and Wang, 2009); computer (Kumar 
and Putnam, 2008); paper (Pati et al., 2008); and packaging material (Skinner et al., 2008). 
 
Reverse supply chain management (RSCM) is defined as the effective and efficient management of 
the series of activities required to retrieve a product from a customer in order to either dispose of it 
or recover value (Defee et al., 2010). The research on reverse logistics has tended to focus on 
automobiles, metal scraps, sales packaging material, waste paper recycling (Kumar and Putnam, 
2008; Skinner et al., 2008). However, in recent years, research on reverse logistics in the 
pharmaceutical industry has begun to be reported. A representative example is that of Aurora Health 
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Care Pharmacy, which keeps returns at less than 2% of its total inventory despite stringent 
regulations related to expiration dates, manufacturer recalls and proper disposal of drugs (Morton, 
2006). Nevertheless, academic researchers and practitioners believe that pharmaceuticals are 
different and they cannot be treated like other commodities (Savage et al, 2006).  The reasons for 
this sentiment appear to be the level of regulation in the product production, storage, distribution, 
consumption and the complexity of the fabric of this supply chain (Porter and Teisberg, 2006). 
 
Lean is defined as an improvement philosophy that focuses on continually improvement of a process 
by removing waste, increasing efficiency and providing higher quality product or service (Brandao de 
Souza, 2009). Lean was originally applied in the industrial sector; however in recent years there have 
been significant interventions in other areas including healthcare (Lodge and Bamford, 2008). It has 
met with great success in healthcare organisations across the world from hospitals in the USA (Savary 
and Crawford-Mason, 2006), Australia (Bem-Tovim et al., 2007) and the UK (Fillingham, 2007), in 
both the acute (Joosten et al. 2009) and community settings (Grove et al. 2010).  
 
HoldeŶ͛s (2011) review of lean applications in Accident and Emergency department shows that lean 
can contribute to decreases in waiting times, length of stay, and the proportion of patients leaving 
without being seen. Similar results have been reported by Kelly et al. (2007), in their project, where 
an emergency department was analysed and redesigned using lean principles. Moreover, research 
indicates that Lean implementation resulted in reduced lead-time (Al-Araidah et al., 2010), clinical 
errors (Raab et al., 2006), inappropriate procedures (Van Lent et al., 2009) and enhanced patient and 
staff satisfaction (Dickson et al., 2009).  
 
The literature has revealed that Lean applications have been more applied in physical health service 
settings, focusing on the improvement of patients flow.  Moreover, at present there is weak tangible 
evidence on how Lean can influence other healthcare services such as the delivery of medicines. 
 
Description of the challenge 
 
One of the growing concerns in the pharmaceutical industry is related to the particular 
characteristics of medicines; drugs can be converted into dangerous or useless products for 
consumers due to their short expiration dates (Cherrett et al., 2012).  Moreover, the disposal of 
expired/unwanted medication can be very costly and harmful to the environment. Therefore, 
hospital pharmacies concentrate on innovative programmes to reduce waste and costs, while 
improving quality of services (Odier, 2010).  The UK Department of Health produced a series of 
guidelines on best practice waste management to help healthcare organisations deal with these kind 
of issues (DoH, 2012). In addition to this, Xie and Breen (2012), in their research, designed a green 
community Pharmaceutical Supply Chain (PSC) that reduces preventable pharmaceutical waste and 
effectively disposes of inevitable pharmaceutical waste, using a cross boundary green PSC approach 
that requires every participant in the PSC to take environmental practices. 
 
Outside the area of community pharmacies hospitals concentrate on innovative programmes to 
reduce waste and costs, while improving the quality of services (Odier, 2010). However, there is a 
need for further research to identify the root causes of waste within the PSC.  Consequently, the aim 
of this research is to gain a better understanding of wastage in the PSC and to assess how Lean and 
reverse logistics can improve the delivery of medicine. To structure the investigation two research 
questions (RQs) were developed:  
RQ1: What are the root causes of medicine waste in a hospital pharmacy in the UK?  
RQ2: What is the impact of Lean thinking on medicines waste reduction? 
 
The research methods 
 
The research study adopted a qualitative approach; the methodology was designed to analyse 
qualitative data, to identify and understand the causes and potential solutions. This data was 
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collected via a series of site visits and one-to-one interviews with key pharmacy professionals within 
the NHS. Questions were formulated and grounded in academic theory and professional practice and 
were reviewed and revised post the initial pilot site visits/interviews.  A total of 10 pharmacists from 
4 hospitals were interviewed in a semi-structured manner. Each interview lasted approximately 50 
minutes. Participants were asked a series of questions focusing on current practices in hospital 
pharmacies and the PSC, current measurement of waste, and the benefits/potential of reverse 
logistics application.  
 
A case study approach (Yin, 2008) was adopted to gather and assess the data in order to have a 
better insight of the PSC in the NHS. The case study focuses on the drug delivery process within the 
NHS. In particular, it describes the delivery of medicines from the hospital pharmacy to wards and 
vice versa.   
 
Findings 
 
The application of Lean thinking within the case study has provided the opportunity to establish the 
current state of operational processes within not only the forward components but also the reverse 
components of the defined pharmaceutical logistics process, identifying the root cause of the waste.  
According to the respondents the main waste identified was at ward level in hospitals as the ward 
staff, have to manage their own stock of medicines and deal with patients as well and hence have 
limited time to focus on stock related issues. This is also not an essential part of their nursing role 
and therefore they are not trained to effectively manage stock rotation hence stockpiling and 
obsolescence occurs It is worth mentioning that a hospital pharmacy supplies approximately £30 
million pounds of medication per annum of which £36,000 per annum (£3,000 per month) is 
returned and reused (Respondent A). 
 
From the collated primary research the following is an indication of the set-up and physical 
distribution of the PSC: 
Hospital pharmacies tend to order the majority of items five days per week, twice a day. However, 
order frequency will depend upon the type of product and how often it is needed.  For example, 
some stock is received twice a week, such as the large bags of fluids, some of them might do next day 
delivery and others can only deliver on a specific day. Therefore, there are ten or eleven deliveries 
from each wholesaler per week. The stores departments are tasked with having no more than two 
weeks stock (an average).  However, there are some lines/types of medicines that might only be used 
once a year - but they have to be kept (just in case).  On the other hand to offset and balance it out, 
another line/type of medicine may only have one or two days stock.  This described strategy is based 
upon actual usage figures within the hospital pharmacies. 
 
With this system, there is a potential risk regarding the storage of medicines due to their short 
expiration dates. Pharmacists do stock checked the whole stored supply during the year, but the 
expiry date check should happen every month; formal systems and procedures prompt them to 
annotate on the medicine packaging/box that it is going out of date.  However, there tends to be an 
agreement between the Co-operative and the hospital pharmacy where if the hospital pharmacy 
discovers a short dated item, it can swap it with the Co-operative that they might use it more 
frequently and vice versa (Respondent B).  
 
Hospital Pharmacies supply the wards with one week of stock in order to be able to treat patients in 
a timely manner. It has been observed that the majority of the medicines ͚wasted͛ occur on the 
patient wards.  One reason appears to be that staff there does not manage their stock correctly.  
Formally the wards have to stock check their own supplies; they are required to check the expiry 
date to make sure they are not giving out-of-date medication.  Another problem reported during the 
research is that discharge medication is commonly issued to the wards but the patient has left before 
the medication is ready.  However, these medicines can be returned back to pharmacy and re-used. 
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In one hospital pharmacy approximately £3,000 per month of stock is re-used from this method, a 
positive action.  Unfortunately a negative impact is that the pharmacists have already labelled the 
medicines and dispensed them (all of which takes time), then of course they have to put them back 
into the stock system.  On the other hand there are some medicines that cannot be re-used, for 
example, in order that antibiotic syrups are ready for consumption, water has to be added and if that 
happens they must be taken within seven days otherwise they become unusable.  In addition to this, 
medication that is issued by, for example, a community pharmacy of another hospital is not allowed 
to be reused.  This is guidance from the General Pharmaceutical Council (Respondent A); their 
rationale being that the quality of those medicines cannot be attested regards source and control.  
Furthermore, it was reported that some medicines might be unlabelled and according to the 
guidance from the General Pharmaceutical Council, they cannot be used until they have been 
correctly identified. 
 
In the patient wards there are Pharmacy Returns Boxes.  These are grey lockable boxes to put the 
leftover or unusable medicines in.  Subsequently these boxes are returned back to the pharmacy 
where the medicines that can be reused are separated from those that have to be destroyed.  
Unfortunately at this point most pharmacies do not collate the data from the returns.  Additionally, 
there are Yellow Bins in each ward for ͚dropped͛ medication, for example, some injections need to be 
wasted because only the 1ml of the 5ml that one ampoule contains, is needed and the rest of it 
cannot be reused.  Therefore, the Yellow Bins include products that have to be physically incinerated.  
 
Figure 1 illustrates the perceived process map of drug delivery in the NHS. The arrows show the 
forward logistics process and the dashed arrows the way that items can be reused or destroyed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The process map of drug delivery in the NHS 
 
As can be seen from the above figure:  The hospital pharmacy receives its supplies of medicines from wholesalers and 
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1. On the wards, there is stock cupboards with medication which is not patient specific 
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Discussion  
 
In this paper hospital pharmacies and the way that they supplies medication within hospitals have 
been used as a case study to have a better understanding of the delivery process. Furthermore, the 
application of Lean thinking within the case study was considered necessary in order to begin the 
establishment of the current state of operational processes and to identify the root cause of the 
waste.  The drug delivery process map revealed a high number of process wastes occurring within 
pharmacies.  These are summarised in Table 1. 
 
Duplication   Discharged medication has been issued to the wards when patients 
have already left –approximately £3,000 per month of stock is re-
used from this method  Separation of the medicines that can be reused by those that have 
to be destroyed 
Waiting   Labelling the medicines  
Defect/Error  Unlabelled medicines   Inappropriate packaging of medication 
Inappropriate processing   Wards do not manage their stock properly   Discharged medication has been issued to the wards when patients 
have already left  The medication was issued by another hospital and is not 
allowed to be reused (General Pharmaceutical Council 
guidance) 
Unnecessary inventory  Some medicines need to be stored according to national guidance, 
i.e. the antidotes for poisoning   On the wards, the stock cupboards contain more items than it is 
required / recorded  The periodic lack of adequate storage capacity  
Unnecessary motion  Nurses ask for required medication 
Table 1: Operational process wastes identified within a hospital 
 
Analysis revealed that the root cause of operational process wastes appear to stem from not 
following agreed procedures.  For example, there is supposed to be a three monthly stock check of 
expiry dates; when these do not occur then the products are more likely to unknowingly expire.  A 
solution to this problem may be found by applying the Kanban, one of the main tools of the lean 
philosophy (Brandao de Souza, 2009).  Research suggests that the application of this tool can help 
the pharmacists to manage their stock correctly and also eliminate waste (Papalexi, 2010). Papalexi 
(2010) suggested a group of cooperative pharmacists that their organisation can store 56.8% fewer 
products and spend 71.8% less money, by adopting the kanban system. 
 
Another equally important cause of waste is unnecessary stock holding.  In other words, employees 
on the wards do not realise the actual value of the stock kept in the ward cupboards.   They tend to 
request more products than they need; operating a ͚just iŶ Đase͛ Ŷot ͚just iŶ tiŵe͛ sǇsteŵ.  As a 
result, these items can expire and not be available when actually needed. A series of seminars and 
facilitated workshops is often the answer to this problem. Hazen et al. (2014) highlight the need for 
training and education of key stakeholders to embrace a more holistic food supply chain.  This data 
can actively inform the supply and replenishment of medicines; the ability to predict provides an 
ability to control (Bamford, 2010). 
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A series of seminars and facilitated workshops may also contribute to improving reverse logistics 
processes. In particular, it would be an opportunity for the key stakeholders of the internal PSC to be 
aware of what items can be reused-recycled or have to be destroyed. As a result, this knowledge 
could reduce the waste associated with duplication, decreasing the workload of the pharmacists.    
 
Poor communication between the stakeholders does increase the level of wastage. Better 
communication between pharmacists and doctors can minimise the amount of discharged 
medication prepared without reason.  Furthermore, communication tends to be one of the main 
factors that impact upon managing returns (Breen, 2006). Drummond-Hay and Bamford (2009) 
suggest that successful improvements are subjected to an agreement that everyone within an 
organisation should work in one direction. Moreover, the waste occurring by not using medicines 
that have been issued by another hospital may be reduced; perhaps some national consultation with 
the General Pharmaceutical Council could contribute to a solution for this particular problem.  
Seddon and Caulkin, (2007) highlighted that the services measured by central government often 
demonstrated little improvement.  
 
In conclusion, analysis of the management related causes led to the structure of a classification of 
factors affecting pharmaceutical waste. These are presented in Table 2.  
 
Supply Chain Management Quality Control 
Planning and information flow Product Specifications 
Availability and inventory management Shelf-life management 
Job design Packaging and labelling 
Table 2: Classification of causes of medication waste 
 
The first includes issues related to supply and the second to quality of medication. This classification 
has been adopted by Mena et al. (2014) who identified the dominant causes of waste and the 
operational issues within food networks. 
 
Supply chain management is associated with data quality and impact the availability of products 
(Hazen et al., 2014). Regarding the pharmaceutical supply chain within hospitals, planning and 
information flow are weak due to poor communication between the providers of healthcare services; 
a fact that influences the availability of medicines. Furthermore, weaknesses related to quality and 
process control has also been observed within the pharmaceutical logistics process. The data analysis 
revealed that issues related to product specifications, shelf-life management, packaging and labelling 
have been reported.  
 
Conclusion 
 
This research began with the development of an understanding of wastage in pharmaceutical supply 
chain. In particular, the paper focused on the medication delivery process within the NHS. The study 
has demonstrated that by using Lean thinking, the current state operational processes can be 
established within the forward and reverse supply chain logistics, identifying the root causes of 
waste. A series of improvement solutions were identified which focused on improving stock 
management, data quality and communication between the providers of healthcare services. 
 
The main limitation of this research was the timeline available to investigate this particular research 
area. As a result, with the time limitation, only 10 pharmacists were interviewed and certain figures 
were collected. To remain focused, this research focused on the distribution of medicines within NHS 
without taking into account the whole PCS. In addition, the research based exclusively in the UK and 
might have missed important causes of waste that are not prevalent in this country. Therefore, there 
is scope for further research in this area.  Additional work can be completed on a broader analysis of 
the PSC, including the stakeholders such as pharmaceutical companies or wholesalers. Moreover, the 
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expansion of this research into other countries could lead to a better insight of the PSC and the root 
cause of waste occurring.      
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